TZP-102 Uses, Dosage, Side Effects and more
TZP-102 is under investigation in clinical trial NCT01452815 (Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis).
Trade Name | TZP-102 |
Generic | TZP-102 |
Type | |
Formula | C28H44N4O4 |
Weight | Average: 500.684 Monoisotopic: 500.336255913 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |